Request Discount

Embolotherapy Market (Product - Embolic Agents, and Support Devices; Disease - Oncology, Peripheral Vascular, Gastrointestinal Disorders, and Other Diseases; End-user - Hospitals, Clinics, Academia, and Ambulatory Surgical Centers): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : October, 2019

  • Rep Id : ICT1290

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Embolotherapy Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Embolotherapy Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Embolotherapy Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on embolotherapy market provides an in-depth analysis of segments and sub-segments in the global as well as regional embolotherapy market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional embolotherapy market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global embolotherapy market. According to the report, the global embolotherapy market is projected to grow at a CAGR of 8.0% over the forecast period of 2019-2025.


Market Insight

Embolotherapy is an endovascular treatment. Embolotherapy uses minimally invasive techniques and different embolic agents like gelfoam, coils, balloons, and angiographic catheters that achieve precise results. The leading players are investing in research and development to promote innovations in the global embolotherapy market. Companies operating in the global embolotherapy market are adopting strategies such as mergers, acquisitions, and new product launches that expand their market share. In 2018, Stryker Corporation acquired Entellus Medical which delivers products for minimally invasive treatment of different diseases.


The surge in demand for minimally invasive procedures drives the growth of the embolotherapy market. The growing prevalence of peripheral vascular diseases, strokes, liver cancer, and uterine fibroids contributes to the growth of the embolotherapy market. Increasing research and development investments in healthcare sector stimulate the growth of embolotherapy market. The growing geriatric population promotes the growth of the embolotherapy market. In addition, the favourable reimbursement scenario in the market contributes to the growth of the embolotherapy market. On the other side, stringent regulations for product commercialization hinder the growth of the embolotherapy market. Moreover, technological development in the healthcare sector creates several opportunities for the growth of the embolotherapy market.


Based on geography, the global embolotherapy market is classified into North America, Asia-Pacific, Europe, and the Rest of the World. North America is anticipated to have a premium share in the global embolotherapy market. The growing adoption of minimally invasive methods and rising technological development in embolotherapy equipment in North America drive the growth of the embolotherapy market. Asia-Pacific region is expected to grow in the global embolotherapy market with a significant CAGR over the forecast period. The increasing healthcare infrastructure and rising prevalence of target diseases in the Asia-Pacific region contribute to the growth of the embolotherapy market. Europe is showing growth in the global embolotherapy market.

Global Embolotherapy Market


Segment Covered

The report on global embolotherapy market covers segments such as product, disease, and end-user. On the basis of product, the sub-markets include embolic agents, and support devices. On the basis of disease, the sub-markets include oncology, peripheral vascular, gastrointestinal disorders, and other diseases. On the basis of end-user, the sub-markets include hospitals, clinics, academia, and ambulatory surgical centers.


Companies Profiled:

The report provides profiles of the companies in the market such as Balt Extrusion SAS, Medtronic plc, Merit Medical Systems, Inc., Penumbra, Inc., Terumo Medical Corporation, Stryker Corporation, Kaneka Corporation, Abbott Laboratories S.A., Acandis GmbH & Co KG, Boston Scientific Corporation, and other companies.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of embolotherapy market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount